How Exercise May Protect Bones and Blood Sugar in Type 1 Diabetes

People with Type 1 diabetes face two overlapping health concerns: high blood sugar and weakened bones. Osteoporosis—a condition where bones become fragile and more prone to fracture—is increasingly recognized as a complication of Type 1 diabetes. Understanding how exercise helps address both problems could improve long-term health outcomes.

While exercise is known to help with blood sugar control and bone health, scientists have not fully mapped out the molecular pathways that make this happen. A new study in mice offers some clues about one key mechanism at work.

Researchers gave mice with Type 1 diabetes a structured exercise program: 20 minutes of treadmill running at a moderate pace, six days a week, for six weeks. This regimen produced measurable improvements.

Exercising mice developed stronger bones with better internal structure and more normal appearance under the microscope. Their blood sugar levels also improved significantly. These results suggest that regular physical activity can help mitigate two major complications of Type 1 diabetes.

To understand how exercise works at the cellular level, the research team studied a protein called Piezo1, which acts like a mechanical sensor inside cells. When physical stress—such as the repeated movements of exercise—activates Piezo1, it triggers a cascade of changes inside cells.

When scientists applied mechanical stretch to bone cells in the laboratory, cells with a working Piezo1 protein responded by building stronger bone tissue and improving glucose metabolism. However, when they tested cells engineered without functional Piezo1, these protective effects nearly disappeared. This finding suggests Piezo1 is crucial for translating the mechanical signals of exercise into cellular benefits.

This research provides a molecular foundation for understanding why exercise helps people with Type 1 diabetes manage both bone density and blood sugar. The discovery that Piezo1 plays a central role opens the door to developing new treatments that might mimic or enhance this natural protection.

It is important to note that this study was conducted in mice and laboratory cells, not humans. While the findings are promising, clinical trials in people with Type 1 diabetes would be needed to confirm whether these mechanisms operate the same way and whether new Piezo1-targeted therapies could offer real benefits. In the meantime, the results reinforce the value of regular physical activity as part of Type 1 diabetes management.

Source: Biology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.